The role of abnormal vitreomacular adhesion in age-related macular degeneration: spectral optical coherence tomography and surgical results. - Wikidata - awgldk - TriplyDB

The role of abnormal vitreomacular adhesion in age-related macular degeneration: spectral optical coherence tomography and surgical results.

The role of abnormal vitreomacular adhesion in age-related macular degeneration: spectral optical coherence tomography and surgical results.

http://www.wikidata.org/entity/Q33341287

about

Effects of Vitreomacular Adhesion on Age-Related Macular Degeneration Clinical applications of optical coherence tomography in the posterior pole: the 2011 José Manuel Espino Lecture - Part II Ocriplasmin: who is the best candidate?Posterior vitreous detachment following intravitreal drug injection.Profile of ocriplasmin and its potential in the treatment of vitreomacular adhesion Full-thickness macular hole formation following anti-VEGF injections for neovascular age-related macular degeneration.Long-term SD-OCT/SLO imaging of neuroretina and retinal pigment epithelium after subthreshold infrared laser treatment of drusen.Displacement of submacular hemorrhage associated with age-related macular degeneration using vitrectomy and submacular tPA injection followed by intravitreal ranibizumab Spectral domain OCT versus time domain OCT in the evaluation of macular features related to wet age-related macular degeneration.Three dimensional optical coherence tomography imaging: advantages and advances.Transient visual loss and delayed resolution of vitreomacular traction after intravitreal ocriplasmin.Optical coherence tomography: history, current status, and laboratory work.Breast cancer medications and vision: effects of treatments for early-stage disease.Influence of the Vitreomacular Interface on Treatment Outcomes in the Comparison of Age-Related Macular Degeneration Treatments Trials.Repeatability of Foveal Measurements Using Spectralis Optical Coherence Tomography Segmentation Software Idiopathic preretinal glia in aging and age-related macular degeneration.Decreased VEGF-A and sustained PEDF expression in a human retinal pigment epithelium cell line cultured under hypothermia.Clinical application of ocular imaging miR-126 Regulation of Angiogenesis in Age-Related Macular Degeneration in CNV Mouse Model.Effects of Vitreomacular Traction on Ranibizumab Treatment Response in Eyes with Neovascular Age-related Macular Degeneration Anti-VEGF-refractory exudative age-related macular degeneration: differential response according to features on optical coherence tomography.Bevacizumab and neovascular age related macular degeneration: pathogenesis and treatment.Vitreomacular traction and age-related macular degeneration.Predicting visual outcomes for macular disease using optical coherence tomography.Treating the untreatable patient: current options for the management of treatment-resistant neovascular age-related macular degeneration.Drugs in Phase II clinical trials for the treatment of age-related macular degeneration.A novel cytarabine crystalline lipid prodrug: hexadecyloxypropyl cytarabine 3',5'-cyclic monophosphate for proliferative vitreoretinopathy.Possible vitreous involvement in a case with rapidly progressing choroidal neovascularization.Multimodal imaging and diagnosis of myopic choroidal neovascularization in Caucasians.The effect of vitreomacular adhesion in exudative age-related macular degeneration on the results of ranibizumab intravitreal injection.Retinal pigment epithelium tear after vitrectomy for vitreomacular traction syndrome in an eye with retinal angiomatous proliferation.The vitreomacular interface in different types of age-related macular degeneration.Intracameral concentrations of the fibrinolytic system components in patients with age-related macular degeneration.Prevalence of early and late stages of physiologic PVD in emmetropic elderly population.Efficacy of vitrectomy and inner limiting membrane peeling in age-related macular degeneration resistant to anti-vascular endothelial growth factor therapy, with vitreomacular traction or epiretinal membrane.Effects of posterior vitreous detachment on aqueous humour levels of VEGF and inflammatory cytokines.The role of epiretinal membrane on treatment of neovascular age-related macular degeneration with intravitreal bevacizumab.Correspondence: Spatial variations of viscoelastic properties of porcine vitreous humors.Optical Coherence Tomography in the Diagnosis and Monitoring of Retinal Diseases

P2860

Q26783389-E2272636-356C-4A15-A0B5-194097A6E440 Q26864721-87680744-7C42-4829-939B-B08E52CBBEC8 Q28078808-A3DADB45-01F8-4988-A2D6-42EBF7C2C48B Q30453525-D44ED08D-00AB-40ED-B512-ED625F3B977C Q33599492-A3C9110D-B85A-47EF-B5DA-350423910B0B Q33758281-DCFFFC6C-E886-42D3-81CE-72BBC51D99F6 Q33771755-3DF3A575-9254-449D-BCDE-1416C299DE03 Q34019693-4DE41E9B-DEF8-425C-BBAD-E23793801E4E Q34163112-D9EB59DD-4B7A-4223-9247-212BF84F77C9 Q34233357-984D4D8B-33A8-47C7-B956-36FC930A0B7A Q34610521-01A5B70F-2289-4FC6-89AC-347E01A95B2F Q34936736-A504150C-6ACA-4D26-B220-CD31C34EE76B Q35496778-6B41FE31-50B7-4E47-8A8F-582F50106762 Q35590569-BD115B8C-9A02-418B-8774-5F2B9EAB6C72 Q35664225-B9D6B039-DAE7-4DF8-913B-17CAA9ECC1FD Q35721753-E8FA6200-8F93-486C-905D-59E5F7D16F56 Q35899070-30AF6BC5-8A99-4091-ABC6-1BAAB8D33AF9 Q35947194-A03EB00F-49AF-4F48-A13B-04D92A814F41 Q36060465-1DB02E98-5564-49B3-8A38-3371F8055469 Q36342997-60B2D7BD-7C4A-4416-867E-921EAFEFFDF8 Q37361023-88168F94-58F9-4306-ADBB-81CB783DFCB9 Q37879155-578D6636-234D-431C-B820-0444E7CBD316 Q37879165-50453EA4-6753-4E83-9880-8202CC029839 Q38130239-DA1DEF1E-FEA5-489F-B31E-996FA880293C Q38219895-6D179D58-C204-40CD-ACE3-507EEEBC9490 Q38253067-2783DE02-FAFB-4F6C-8292-23DC9370E3FD Q39300347-19A7B27D-D018-4789-A38B-B0F6C7E06196 Q40569703-A8BCE6A8-C52C-4B2E-9B62-50554EA05702 Q41110065-0817CE64-F3EB-4182-9060-CE7009FDD11D Q41476716-DCCF4DE7-23B5-498C-88E8-158D5871DD32 Q41830406-AB7D2A0A-AC9C-481F-BACD-780BA084AF39 Q42132169-E9890A3A-94AC-4FA5-8BA5-ED5E009CD936 Q43531739-BB06A2E8-C445-4766-975F-E98AA94173D9 Q45282756-BD19D5B5-E8D0-48D5-9EBD-E8BD9898FA4C Q47863735-11296683-8CBB-4940-A576-FEDDE7565216 Q48221078-AB555C1F-3E12-4EFF-BEC4-550B2B26E1D5 Q54334853-7FF21460-A0B5-480B-B32B-AB73F049915B Q55416808-6AF2CFBF-AE87-4EDF-9D8F-53B3B2D6F613 Q59000470-BAA2EAE1-D6A9-4E0D-8A1F-2BE82E424A3A

P2860

The role of abnormal vitreomacular adhesion in age-related macular degeneration: spectral optical coherence tomography and surgical results.

http://www.wikidata.org/entity/Q33341287

description

2008 nî lūn-bûn

@nan

2008 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2008 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

name

The role of abnormal vitreomac ...... mography and surgical results.

@ast

The role of abnormal vitreomac ...... mography and surgical results.

@en

type

label

The role of abnormal vitreomac ...... mography and surgical results.

@ast

The role of abnormal vitreomac ...... mography and surgical results.

@en

prefLabel

The role of abnormal vitreomac ...... mography and surgical results.

@ast

The role of abnormal vitreomac ...... mography and surgical results.

@en

P1433

Q33341287-DA83E2F2-CBA5-4BA2-95D8-4F5C04A9C4FA

P1476

Q33341287-6FD68336-5E33-49C4-BDAD-0B5F9E4A30A2

P2093

Q33341287-1145C0D0-4C87-4A55-B944-DC9BDD775EDD

Q33341287-7EE55D59-C5C8-4E3E-9842-993689B63AD9

Q33341287-C2A14D40-3A76-4881-B80D-CB554D95C231

Q33341287-D3CAF081-E549-426C-8493-D810D6B306C7

Q33341287-D5107230-7DA1-4268-8311-BF493FD0348C

Q33341287-D842ABB7-DC60-4776-A10B-688A72E5779B

Q33341287-D98114C7-9A7C-4282-A525-29E2C55D9F30

P2860

Q33341287-0F4F27DE-34DD-4508-AADA-51C74CFEBAED

Q33341287-18D058F0-1951-43B3-8FBC-9FE820DCC1E7

Q33341287-196AC5D2-C5B0-4E3B-8CF0-D03735522263

Q33341287-1E449F69-DF75-45F4-959C-5C28C42B1E72

Q33341287-33334DCA-0CC2-4F10-8B61-44420AEBA0AB

Q33341287-34674613-F304-4DEF-A9D3-CD0847B2715B

Q33341287-35C6F10A-742A-414D-8AB8-FA288FEEA6EC

Q33341287-3A70D355-F227-426D-AC4E-D38810137051

Q33341287-420961D3-2391-4656-A6F8-D364904DD0DB

Q33341287-4533EE44-39DB-4ED0-8BBA-981969DBDEC2

P304

Q33341287-3F2450A5-9F3E-4F66-B43E-96D2D9C51A95

P31

Q33341287-0C57FCF6-C29D-4FD6-A472-7DAAAB7AFA15

P356

Q33341287-8A5634AC-9A92-4BC0-9F2F-8B8D890E2F70

P407

Q33341287-BCD75BC9-2865-4D81-8A40-898D0CEC7534

P433

Q33341287-6680969E-6649-458A-919E-11AA5EE7A3D4

P478

Q33341287-4EF0F0C6-F3E5-4B59-8E76-0D2FCDD903B4

P577

Q33341287-91BE2980-1EB3-4260-A0B9-6A6D27DADBEB

P5875

Q33341287-7356D4D5-0112-43B7-BABB-C62D758A6F92

P698

Q33341287-7231A987-145A-4087-93CD-BAD63FB11533

P932

Q33341287-E9A507A7-08A1-4F05-9CF4-12D51DD1B3D7

P356

J.AJO.2008.04.027

P1433

American Journal of Ophthalmology

P1476

The role of abnormal vitreomac ...... mography and surgical results.

@en

P2093

Dirk-Uwe G Bartsch

http://www.w3.org/2001/XMLSchema#string

Francesca Mojana

http://www.w3.org/2001/XMLSchema#string

Gabriel A Silva

http://www.w3.org/2001/XMLSchema#string

Igor Kozak

http://www.w3.org/2001/XMLSchema#string

Lingyun Cheng

http://www.w3.org/2001/XMLSchema#string

Nitin Nigam

http://www.w3.org/2001/XMLSchema#string

William R Freeman

http://www.w3.org/2001/XMLSchema#string

P2860

Perifoveal vitreous detachment and its macular complications

Complement factor H polymorphism in age-related macular degeneration

HTRA1 promoter polymorphism in wet age-related macular degeneration

Age-related macular degeneration: epidemiology and optimal treatment.

Surgical excision of subfoveal neovascular membranes in age-related macular degeneration.

Anomalous vitreoretinal adhesions in patients with exudative age-related macular degeneration: an OCT study.

Posterior vitreomacular adhesion: a potential risk factor for exudative age-related macular degeneration?

A role for local inflammation in the formation of drusen in the aging eye.

Differential expression of GFAP in early v late AMD: a quantitative analysis

Current concepts in the pathogenesis of age-related macular degeneration.

P304

218-227

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.AJO.2008.04.027

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

146

http://www.w3.org/2001/XMLSchema#string

P577

2008-06-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5318247

http://www.w3.org/2001/XMLSchema#string

P698

18538742

http://www.w3.org/2001/XMLSchema#string

P932

2735863

http://www.w3.org/2001/XMLSchema#string